Skip to content

Publications

(This page last updated August 2018)

Google Scholar Link


Asthma/Respiratory Research

  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015:  Findings from the Global Burden of Disease 2015 study. International Journal of Public Health, 2017. doi: 10.1007/s00038-017-1007-0
  • Bime C, Fiero M, Lu Z, Oren E, Berry CE, Parthasarathy S, Garcia JGN.  High Positive End Expiratory Pressure is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome. American Journal of Medicine, 2016. http://dx.doi.org/10.1016/j.amjmed.2016.09.029 
  • Oren E, Gerald LB, Stern DA, Martinez FD, Wright AL. Self-reported Stressful Life Events during Adolescence and Asthma. JACI In Practice, 2016.  pii: S2213-2198(16)30416-0. doi: 10.1016/j.jaip.2016.09.019
  • Oren E, Rothers J, Stern, DA, Halonen M, Wright AL. Cough duration during infancy is associated with childhood asthma. Clinical & Experimental Allergy, 2015. 45(9): 1439-1446. DOI: 10.1111/cea.12573* Featured as Editor’s Choice, Clinical & Experimental Allergy, 2015. 45(9)
  • Malo J, Holbrook E, Zangeneh T, Strawter C, Oren E, Robey I, Erickson H, Chahal R, Durkin M, Thompson C, Hoover S, Ampel NM, Wheat J, Knox K. Enhanced antibody detection and diagnosis of coccidioidomycosis with the Miravista IgG and IgM antibody enzyme immunoassay Journal of Clinical Microbiology, 2017. 55: 1-9.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infectious Diseases, 2017. pii: S1473-3099(17)30396-1.

Tuberculosis Research

  • LaCourse SM, Cranmer LM, Bekker A, Steingart KR, Black D, Horne DJ, Oren E, Pals S, Modi S, Mathad J. Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012934. DOI: 10.1002/14651858.CD012934.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. The Lancet Infectious Diseases, 2017. (In press).
  • Oren E, Bell ML, Garcia F, Perez-Velez C, Gerald LB. Promoting Adherence to Treatment for Latent TB Infection through Mobile Phone Text Messaging: Study Protocol for a Pilot Randomized Controlled Trial. Pilot and Feasibility Trials, 2017. 3(15) DOI: 10.1186/s40814-017-0128-9.
  • Jamil SM, Oren E, Garrison GW, Srikanth S, Lewinsohn DM, Wilson KC, Thomson CC. Clinical Practice Guideline: Summary for Clinicians - Diagnosis of Tuberculosis in Adults and Children. Annals of the American Thoracic Society, 2017.  14(2): 275-8.
  • Oren E, Fiero M, Nuῆez M, Barrett E, Hawkins E, Gonzalez-Salazar F. Detection of latent tuberculosis infection among migrant farmworkers. BMC Infectious Diseases, 2016. 16:630. DOI 10.1186/s12879-016-1959-3
  • Osuchukwu O, Blust R, Nuῆez M, Ehiri J, Rosales C, Hawkins E, Aviles J, Gonzalez-Salazar F, Oren E. Acceptability of Latent Tuberculosis Infection Screening among Migrant Farmworkers in Yuma-San Luis, Arizona. International Migration, 2017. 55(5): 62-74.
  • Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Oren E et al. Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.  Plos One. 2016. 11(5):e0155968.
  • Oren E, Alatorre-Isaguirre G, Vargas-Villareal J, Moreno Trevino M, Garcialuna-Martinez J, Gonzalez-Salazar F. Interferon gamma-based detection of latent tuberculosis infection in the border states of Nuevo Leon and Tamaulipas, Mexico.  Frontiers in Public Health. 2015; September 30. http://dx.doi.org/10.3389/fpubh.2015.00220.
  • Oppong JMayer J, Oren E. The Global Health Threat of African Urban Slums: The Example of Urban Tuberculosis. African Geographical Review, 2014. DOI: 10.1080/19376812.2014.91081
  • Li Y, Ehiri J, Oren E, Hu D, Luo X, Liu  Y, Wang Q.Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China. PLOS One, 2014. 9(2):e88330.
  • Campo M, Shrestha A, Oren E, Thiede H, Duchin J, Narita M, Crothers K.  Characterization of Hepatitis C Co-infected Tuberculosis Patients in an Urban City in the US. Epidemiology and Infection, 2013. Sep 25:1-8.
  • Lindquist S, Ghosh-Chatterjee S, Field K, Allen S, Narita M, Oren E. Public Health Prioritization of TB Genotype Clusters. Emerging Infectious Diseases, 2013; 19(3): 493-495.
  • Horne D, Campo M, Arentz M, Oren E, Crothers K, Narita M. Association between Smoking and Latent Tuberculosis in the U.S. Population. PLOS One, 2012;7(11):e49050.
  • Barry PM, Shaw T, Oren E, Field K, Funk E, Langer AJ, Gardner TJ. Multistate Outbreak of Multidrug-Resistant Tuberculosis Identified by Genotype Cluster Investigation among Foreign-Born Seafood Production Workers. Emerging Infectious Diseases, 2012; 18(1): 113-116.
  • Oren E, Winston CA, Pratt R, Robison VA, Narita M. Epidemiology of Urban Tuberculosis in the United States, 2000-2007. American Journal of Public Health. 2011; 101:1256-1263.
  • Horne D, Oren E, Spitters CE, Johnson C, Narita M. How Soon can Smear Positive Tuberculosis Patients be Released from Inpatient Isolation? Infection Control and Hospital Epidemiology. 2010; 31(1): 78-84.
  • Parimon T, Spitters CE, Muangman N, Euathrongchit J, Oren E, Narita M. Unexpected Pulmonary Involvement in Extrapulmonary Tuberculosis Patients. Chest. 2008; 134(3): 589-594.
  • Ashworth M,  Horan KL, Freeman R, Oren E, Narita M, Cangelosi GA. Use of PCR-based Mycobacterium tuberculosis Genotyping to Prioritize Tuberculosis Outbreak Control Activities. Journal of Clinical Microbiology. 2008; 46(3):856-862.
  • Oeltmann JE, Oren E, Haddad MB, Lake LK, Harrington T, Ijaz K, Narita M. Tuberculosis Outbreak in Marijuana Users, Seattle, Washington, 2004. Emerging Infectious Diseases. 2006; 12(7):1156-1159.
  • Freeman R, Kato-Maeda M, Hauge KA, Oren E, Narita M, Wallis CK, Nolan C, Small PM, Cangelosi GA. Use of Rapid Genomic Deletion Typing to Monitor a Tuberculosis Outbreak within an Urban Homeless Population. Journal of Clinical Microbiology. 2005; 43(11):5550-5554.

H. pylori and Cancer Research

  • Driscoll L, Harris R, Brown HE, Oren E. Population Knowledge, Attitude and Practice regarding Helicobacter pylori Transmission and Outcomes: A Literature Review. Frontiers in Public Health, 2017. 5:144. doi: 10.3389/fpubh.2017.0014
  • Murakami T, Scranton R, Brown H, Harris RB, Chen Z, Musuku S, Oren E. Management of Helicobacter Pylori in the United States: Results from a National Survey of Gastroenterology Physicians. Preventive Medicine, 2017. 100: 216-222.
  • Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiology, Biomarkers and Prevention. 2016. 25(7): 1018-1028.
  • Bui D, Harris RB, Brown H, Oren E. The Association between Helicobacter pylori and Hepatitis A in the United States: Serologic Evidence for Fecal-oral Transmission of H. pylori from the National Health and Nutrition Examination Surveys.  American Journal of Tropical Medicine & Hygiene, Published online November 23, 2015; doi:10.4269/ajtmh.15-0297
  • Kohler LN, Hibler EA, Harris RB, Oren E, Roe DJ, Jurutka PW, Jacobs ET. Greater adherence to cancer prevention guidelines is associated with higher circulating concentrations of vitamin D metabolites in a cross-sectional analysis of pooled participants from two chemoprevention trials. Journal of Nutrition, 2017. doi: 10.3945/jn.116.243352
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 2016. doi:10.1001/jamaoncol.2016.5688

Vaccine Research

  • Haenchen S, Jacobs B, Pottinger H, Oren E, Ernst K. Perceptions of Personal Belief Vaccine Exemption Policy: A Survey of Arizona Vaccine Providers. Vaccine, 2014. DOI: 10.1016/j.vaccine.2014.04.081

Social Epidemiology Research

  • Valdez LA, Flores M, Garcia DO, Ruiz J, Oren E, Carvajal S. Gender and Cultural Adaptations for Diversity: A Systematic Review of Alcohol and Substance Abuse Interventions for Latino Males (In press, Substance Use and Abuse).
  • Li Y, Ehiri J, Hu D, Oren E, Cao J.Framework of behavioral indicators for outcome evaluation of TB health promotion: a Delphi study of TB policy makers and health workers. Infectious Diseases of Poverty. 2015; 4(1). DOI:10.1186/s40249-015-0087-4
  • Oren E, Koepsell T, Leroux B, Mayer J. Area-based Socioeconomic Disadvantage and Tuberculosis Incidence. International Journal of the Union against TB and Lung Disease, 2012; 16(7):880-5
  • Oren E, Narita M, Nolan C, Mayer J. Neighborhood socioeconomic position and tuberculosis transmission: a retrospective cohort study. BMC Infectious Diseases, 2014.14:227.
  • Colvin C, Mugyabuso J, Munuo G, Lyimo J, Oren E, et al. Evaluation of community based interventions to improve TB case detection in Tanzania. Global Health: Science and Practice, 2014. 2(2): 219-225.
  • Oren E, Narita M, Nolan C, Mayer J. The role of area-level socioeconomic disadvantage on severe pulmonary tuberculosis: U.S., 2000-2008. Public Health Reports, 2013; 128: 99-109.

Global Burden of Disease

  • Global Burden of Disease Study 2016 Collaborators, including Oren E. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. The Lancet Infectious Diseases, 2017. (In press).
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1345-1422.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1260-1344.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1211-1259.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1151-1210.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1084-1150.
  • Global Burden of Disease Study 2016 Collaborators, including Oren E. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet, 2017. 390 (10100): 1423-1459.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infectious Diseases, 2017. pii: S1473-3099(17)30396-1.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Aug 16. pii: S2213-2600(17)30293-X.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015:  Findings from the Global Burden of Disease 2015 study. International Journal of Public Health, 2017. doi: 10.1007/s00038-017-1007-0.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Healthcare Access and Quality Index based on mortality from causes amenable to personal healthcare in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease 2015 study Lancet, 2017. 390 (10091):231–66.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 2016. doi:10.1001/jamaoncol.2016.5688
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. The Lancet HIV, 2016. 3(8): e361-87.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Measuring the health-related Sustainable Development Goals in 188 countries: A baseline analysis from the Global Burden of Disease Study  2015. The Lancet. 2016. 388 (10053): 1813-1850.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national life expectancy, all‐cause and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1459–544.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E.  Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 195 countries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1659-724.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1603–58.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1725-74.
  • Global Burden of Disease Study 2015 Collaborators, including Oren E. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 2016. 388 (10053): 1775-812.

Other Infectious Disease Research

  • Hansen V, Oren E, Dennis L, Brown, H. Infectious Disease Mortality Trends in the United States. JAMA, 2016. 316 (20): 2149-2151.

Health Technology

  • Oren E, Shaffer ER and Guglielmo BJ. Impact of Emerging Technologies Upon Medication Errors and Adverse Drug Events: A Review of the Evidence. American Journal of Health-System Pharmacists 2003; 60:1447-1458.
  • Oren E, Griffiths LP and Guglielmo BJ. Demographics of Antimicrobial Overrides Associated with Automated Dispensing Machines. American Journal of Health-System Pharmacists 2002; 59 (15): 1445-1448.
  • Oren E, McCart G, Phillips KA. Evaluating the Potential Impact of Pharmacogenomics on ADRs: A Subject Review. Journal of Managed Care Pharmacy 2002; 8 (4): 285-290.
  • Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. Journal of the American Medical Association 2001; 286 (18): 2270-2279.

Systematic Reviews (may be duplicative of content area listing)

  • Valdez LA, Flores M, Garcia DO, Ruiz J, Oren E, Carvajal S. Gender and Cultural Adaptations for Diversity: A Systematic Review of Alcohol and Substance Abuse Interventions for Latino Males. Substance Use and Abuse. 2018. https://doi.org/10.1080/10826084.2017.1417999
  • LaCourse SM, Cranmer LM, Bekker A, Steingart KR, Black D, Horne DJ, Oren E, Pals S, Modi S, Mathad J. Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012934. DOI: 10.1002/14651858.CD012934.
  • Fiero M, Huang S, Oren E, Bell ML. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review. Trials. 2016; 17 (72). DOI: 10.1186/s13063-016-1201-z
  • Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiology, Biomarkers and Prevention. 2016. 25(7): 1018-1028.
  • Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. Journal of the American Medical Association 2001; 286 (18): 2270-2279.

Other Methodology and Content

  • Fiero M, Huang S, Oren E, Bell ML. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review. Trials. 2016; 17 (72). DOI: 10.1186/s13063-016-1201-z
  • Oren E, Smith NL, Doggen CJ, Heckbert SR, Lematire RN. Body mass index and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost. 2006 Oct;4(10):2273-5.
  • Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E. Out-of-pocket Expenditures for Oral Contraceptives and Number of Pill Packs Obtained per Purchase. Journal of the American Women’s Medical Association. 2004;59(1):36-42.